Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review)
- Authors:
- Yong-Ju Gao
- Bo Li
- Xin-Yu Wu
- Jing Cui
- Jian-Kui Han
-
Affiliations: Department of Nuclear Medicine, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China, Department of Nuclear Medicine, Henan Provincial People's Hospital and the People's Hospital of Zhengzhou University, Zhengzhou, Henan 450003, P.R. China - Published online on: January 14, 2014 https://doi.org/10.3892/or.2014.2978
- Pages: 1035-1042
-
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].
This article is mentioned in:
Abstract
Sherman SI: Thyroid carcinoma. Lancet. 361:501–511. 2003. View Article : Google Scholar : PubMed/NCBI | |
Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar | |
Pilotti S, Collini P, Manzari A, Marubini E and Rilke F: Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns? Semin Diagn Pathol. 12:249–255. 1995.PubMed/NCBI | |
Nishida T, Katayama S, Tsujimoto M, Nakamura J and Matsuda H: Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol. 23:205–211. 1999. View Article : Google Scholar : PubMed/NCBI | |
Aratake Y, Nomura H, Kotani T, et al: Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study. Am J Clin Pathol. 125:399–406. 2006. View Article : Google Scholar | |
Rosen JM and Jordan CT: The increasing complexity of the cancer stem cell paradigm. Science. 324:1670–1673. 2009. View Article : Google Scholar : PubMed/NCBI | |
Gupta PB, Chaffer CL and Weinberg RA: Cancer stem cells: mirage or reality? Nat Med. 15:1010–1012. 2009. View Article : Google Scholar : PubMed/NCBI | |
Ke CC, Liu RS, Yang AH, et al: CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. Eur J Nucl Med Mol Imaging. 40:61–71. 2013. View Article : Google Scholar : PubMed/NCBI | |
Zheng X, Cui D, Xu S, Brabant G and Derwahl M: Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol. 37:307–315. 2010.PubMed/NCBI | |
Todaro M, Iovino F, Eterno V, et al: Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res. 70:8874–8885. 2010. View Article : Google Scholar : PubMed/NCBI | |
Yun JY, Kim YA, Choe JY, et al: Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome. J Clin Pathol. Aug 28–2013.(Epub ahead of print). View Article : Google Scholar | |
Takano T: Fetal cell carcinogenesis of the thyroid: theory and practice. Semin Cancer Biol. 17:233–240. 2007. View Article : Google Scholar : PubMed/NCBI | |
Takano T and Amino N: Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid. 15:432–438. 2005. View Article : Google Scholar : PubMed/NCBI | |
Ratajczak MZ: Cancer stem cells - normal stem cells ‘Jedi’ that went over to the ‘dark side’. Folia Histochem Cytobiol. 43:175–181. 2005. | |
Dalerba P, Cho RW and Clarke MF: Cancer stem cells: models and concepts. Annu Rev Med. 58:267–284. 2007. View Article : Google Scholar : PubMed/NCBI | |
Zhu L, Gibson P, Currle DS, et al: Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature. 457:603–607. 2009. View Article : Google Scholar : PubMed/NCBI | |
Barker N, Ridgway RA, van Es JH, et al: Crypt stem cells as the cells-of-origin of intestinal cancer. Nature. 457:608–611. 2008. View Article : Google Scholar : PubMed/NCBI | |
Chaffer CL, Brueckmann I, Scheel C, et al: Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci USA. 108:7950–7955. 2011. View Article : Google Scholar : PubMed/NCBI | |
Kondo T, Ezzat S and Asa SL: Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer. 6:292–306. 2006. View Article : Google Scholar : PubMed/NCBI | |
Albores-Saavedra J, Hernandez M, Sanchez-Sosa S, Simpson K, Angeles A and Henson DE: Histologic variants of papillary and follicular carcinomas associated with anaplastic spindle and giant cell carcinomas of the thyroid: an analysis of rhabdoid and thyroglobulin inclusions. Am J Surg Pathol. 31:729–736. 2007. View Article : Google Scholar | |
Lan L, Luo Y, Cui D, et al: Epithelial-mesenchymal transition induces cancer stem cell generation in human thyroid cancer cells in vitro. Zhonghua Yi Xue Za Zhi. 93:1261–1265. 2013.(In Chinese). | |
Yasui K, Shimamura M, Mitsutake N and Nagayama Y: SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells. Thyroid. 23:989–996. 2013. View Article : Google Scholar : PubMed/NCBI | |
Mani SA, Guo W, Liao MJ, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI | |
Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI | |
Clarke MF, Dick JE, Dirks PB, et al: Cancer stem cells - perspectives on current status and future directions: AACR Workshop on Cancer Stem Cells. Cancer Res. 66:9339–9344. 2006. View Article : Google Scholar | |
Ailles LE and Weissman IL: Cancer stem cells in solid tumors. Curr Opin Biotechnol. 18:460–466. 2007. View Article : Google Scholar : PubMed/NCBI | |
Golebiewska A, Brons NH, Bjerkvig R and Niclou SP: Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell. 8:136–147. 2011. View Article : Google Scholar : PubMed/NCBI | |
Pastrana E, Silva-Vargas V and Doetsch F: Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell. 8:486–498. 2011. View Article : Google Scholar : PubMed/NCBI | |
Douville J, Beaulieu R and Balicki D: ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev. 18:17–26. 2009. View Article : Google Scholar : PubMed/NCBI | |
Greve B, Kelsch R, Spaniol K, Eich HT and Gotte M: Flow cytometry in cancer stem cell analysis and separation. Cytometry A. 81:284–293. 2012. View Article : Google Scholar : PubMed/NCBI | |
Thomas T, Nowka K, Lan L and Derwahl M: Expression of endoderm stem cell markers: evidence for the presence of adult stem cells in human thyroid glands. Thyroid. 16:537–544. 2006. View Article : Google Scholar : PubMed/NCBI | |
Grosse-Gehling P, Fargeas CA, Dittfeld C, et al: CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol. 229:355–378. 2013. View Article : Google Scholar : PubMed/NCBI | |
Miraglia S, Godfrey W, Yin AH, et al: A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 90:5013–5021. 1997.PubMed/NCBI | |
Zito G, Richiusa P, Bommarito A, et al: In vitro identification and characterization of CD133poscancer stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS One. 3:e35442008. View Article : Google Scholar : PubMed/NCBI | |
Friedman S, Lu M, Schultz A, Thomas D and Lin RY: CD133+anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS One. 4:e53952009. | |
Zhu W, Hai T, Ye L and Cote GJ: Medullary thyroid carcinoma cell lines contain a self-renewing CD133+population that is dependent on Ret proto-oncogene activity. J Clin Endocrinol Metab. 95:439–444. 2010. View Article : Google Scholar : PubMed/NCBI | |
Lin RY: New insights into thyroid stem cells. Thyroid. 17:1019–1023. 2007. View Article : Google Scholar : PubMed/NCBI | |
Goodell MA, Brose K, Paradis G, Conner AS and Mulligan RC: Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 183:1797–1806. 1996. View Article : Google Scholar : PubMed/NCBI | |
Robinson SN, Seina SM, Gohr JC, Kuszynski CA and Sharp JG: Evidence for a qualitative hierarchy within the Hoechst-33342 ‘side population’ (SP) of murine bone marrow cells. Bone Marrow Transplant. 35:807–818. 2005.PubMed/NCBI | |
Hoshi N, Kusakabe T, Taylor BJ and Kimura S: Side population cells in the mouse thyroid exhibit stem/progenitor cell-like characteristics. Endocrinology. 148:4251–4258. 2007. View Article : Google Scholar : PubMed/NCBI | |
Mitsutake N, Iwao A, Nagai K, et al: Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology. 148:1797–1803. 2007. View Article : Google Scholar : PubMed/NCBI | |
Steuer B, Breuer B and Alonso A: Differentiation of EC cells in vitro by the fluorescent dye Hoechst 33342. Exp Cell Res. 186:149–157. 1990.PubMed/NCBI | |
Adhikari JS, Khaitan D, Arya MB and Dwarakanath BS: Heterogeneity in the radiosensitizing effects of the DNA ligand Hoechst-33342 in human tumor cell lines. J Cancer Res Ther. 1:151–161. 2005. View Article : Google Scholar : PubMed/NCBI | |
Pillai R, Caria P, Cabras S, Saba F, Vanni R and Sogos V: Thyrospheres enriched in stem-like cells from B-CPAP thyroid cancer cell line: morphomolecular characterization. Italian J Anat Embryol. 116:1432011. | |
Malaguarnera R, Frasca F, Garozzo A, et al: Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid. J Clin Endocrinol Metab. 96:766–774. 2011. View Article : Google Scholar : PubMed/NCBI | |
Li W, Reeb AN, Sewell WA, Elhomsy G and Lin RY: Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells. PLoS One. 8:e650952013. View Article : Google Scholar : PubMed/NCBI | |
Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI | |
Ginestier C, Hur MH, Charafe-Jauffret E, et al: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI | |
Han M and Wu C: Advancement of studies on ALDH1 as a universal marker of stem cells. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 27:1183–1186. 2010.(In Chinese). | |
Feng JQ, Xu ZY, Shi LJ, Wu L, Liu W and Zhou ZT: Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer. J Oral Pathol Med. 42:148–153. 2013. View Article : Google Scholar : PubMed/NCBI | |
Shenoy A, Butterworth E and Huang EH: ALDH as a marker for enriching tumorigenic human colonic stem cells. Methods Mol Biol. 916:373–385. 2012. View Article : Google Scholar : PubMed/NCBI | |
Klonisch T, Hoang-Vu C and Hombach-Klonisch S: Thyroid stem cells and cancer. Thyroid. 19:1303–1315. 2009. View Article : Google Scholar : PubMed/NCBI | |
Carina V, Zito G, Pizzolanti G, et al: Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2. Thyroid. 23:829–837. 2013. View Article : Google Scholar : PubMed/NCBI | |
Schweppe RE, Klopper JP, Korch C, et al: Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab. 93:4331–4341. 2008. View Article : Google Scholar | |
Lee TK, Castilho A, Cheung VC, Tang KH, Ma S and Ng IO: CD24+liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation. Cell Stem Cell. 9:50–63. 2011. | |
Kim E, Kim M, Woo DH, et al: Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells. Cancer Cell. 23:839–852. 2013. View Article : Google Scholar : PubMed/NCBI | |
Tseng LM, Huang PI, Chen YR, et al: Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+cells. J Pharmacol Exp Ther. 341:410–423. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sarkar A and Hochedlinger K: The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell. 12:15–30. 2013. View Article : Google Scholar : PubMed/NCBI | |
Chen G, Xu S, Renko K and Derwahl M: Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. J Clin Endocrinol Metab. 97:E510–E520. 2012. View Article : Google Scholar : PubMed/NCBI | |
Messina M and Robinson BG: Technology insight: gene therapy and its potential role in the treatment of medullary thyroid carcinoma. Nat Clin Pract Endocrinol Metab. 3:290–301. 2007. View Article : Google Scholar : PubMed/NCBI | |
Naughton CK, Jain S, Strickland AM, Gupta A and Milbrandt J: Glial cell-line derived neurotrophic factor-mediated RET signaling regulates spermatogonial stem cell fate. Biol Reprod. 74:314–321. 2006. View Article : Google Scholar : PubMed/NCBI | |
Wang ZY and Chen Z: Acute promyelocytic leukemia: from highly fatal to highly curable. Blood. 111:2505–2515. 2008. View Article : Google Scholar : PubMed/NCBI | |
Short SC, Suovuori A, Cook G, Vivian G and Harmer C: A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer. Clin Oncol (R Coll Radiol). 16:569–574. 2004. View Article : Google Scholar : PubMed/NCBI | |
Naor D, Nedvetzki S, Golan I, Melnik L and Faitelson Y: CD44 in cancer. Crit Rev Clin Lab Sci. 39:527–579. 2002. View Article : Google Scholar | |
De Falco V, Tamburrino A, Ventre S, et al: CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells. Cancer Res. 72:1449–1458. 2012.PubMed/NCBI | |
Liu J and Brown RE: Immunohistochemical detection of epithelial mesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp Pathol. 3:755–762. 2010.PubMed/NCBI | |
Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2:48–58. 2002. View Article : Google Scholar : PubMed/NCBI | |
Dean M, Fojo T and Bates S: Tumour stem cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005. View Article : Google Scholar | |
Hirschmann-Jax C, Foster A, Wulf G, et al: A distinct ‘side population’ of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA. 101:14228–14233. 2004. | |
Feng F, Wang H, Fu H, et al: Dedifferentiation of differentiated thyroid carcinoma cell line FTC-133 is enhanced by 131I pretreatment. Nucl Med Biol. 38:1053–1058. 2011. View Article : Google Scholar : PubMed/NCBI | |
Robbins RJ and Schlumberger MJ: The evolving role of 131I for the treatment of differentiated thyroid carcinoma. J Nucl Med. 46:28S–37S. 2005. | |
Pajonk F, Vlashi E and McBride WH: Radiation resistance of cancer stem cells: the 4 R’s of radiobiology revisited. Stem Cells. 28:639–648. 2010. | |
Milas L and Hittelman WN: Cancer stem cells and tumor response to therapy: current problems and future prospects. Semin Radiat Oncol. 19:96–105. 2009. View Article : Google Scholar : PubMed/NCBI | |
Takakura N: Formation and regulation of the cancer stem cell niche. Cancer Sci. 103:1177–1181. 2012. View Article : Google Scholar : PubMed/NCBI | |
Nie D: Cancer stem cell and niche. Front Biosci. 2:184–193. 2010. View Article : Google Scholar |